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Abstract
Introduction: Diffusion weighted imaging (DWI) has shown its potential as a reliable noninvasive technique for tissue characterization. 
DWI reflects the tissue specific diffusion capacity which can be used for tissue characterization. Hypercellular tissue (e.g; malignant 
tumors) had restricted diffusion capacity with increased signals on DWI and low ADC values. Non-tumoral tissues show low cellularity, 
and diffusion capacity is not restricted resulting in signal loss on DWI and high apparent diffusion coefficient (ADC). Differential diagno-
sis of mediastinal lymphadenopathy is an issue of debate, especially in malignant benign differentiation. Diffusion weighted imaging 
with magnetic resonance could improve the diagnostic accuracy in differentiation between benign and malignant mediastinal nodes.
Objectives: to determine the efficacy of diffusion weighted MRI in evaluation of mediastinal lymphadenopathy with histopatho-
logical correlation to differentiate benign from malignant lymph nodes.
Material and methods: 30 patients with mediastinal lymphadenopathy underwent diffusion weighted MRI. ADCs of lymph nodes 
were derived and constructed from b = 0 and b = 1000 sec/mm2 values by drawing regions of interests (ROI). Consequently, 
mediastinal nodes were studied, biopsies and histopathological analysis were done after MRI examination.
Results: The best cutoff point of ADC to differentiate benign from malignant lesions was 1.15 mm/sec (sensitivity 77%, specificity 
92% and AUC 81.4%). Significant negative correlation of ADC by DW MRI and the size of the LNs. The mean ADC values in the 
lymphoma group was lower than in the sarcoidosis group, and the difference was statistically significant.
Conclusion: The study supports that MRI with diffusion weighted images can differentiate benign from malignant mediastinal 
lymphadenopathy and differentiate lymphoma from sarcoidosis non-invasively.
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Introduction
Lymphadenopathy means abnormal increase in 
size and/or altered consistency of the lymph nodes. 
It is important to differentiate benign from malignant 
lymph nodes [1]. Computed tomography (CT) is the 
standard imaging tool for evaluation of enlarged me-
diastinal lymph nodes, but it has its limitations, and 
it makes lymph node sampling by mediastinoscopy 
or thoracotomy necessary to detect metastases [2].
Diffusion weighted magnetic resonance ima-
ging (DW-MRI) has the potential to be reliable 
noninvasive imaging for tissue characterization. 
Hypercellular tissue like malignant lesions have de-
creased mobility of water protons and consequently, 
restricted diffusion capacity. Thus, tumors present 
with increased signals on DWI and low apparent 
diffusion coefficient (ADC) values. Non-tumoral 
tissues show low cellularity, and consequently, dif-
fusion capacity is not restricted with resulting high 
ADC [3]. An inverse correlation between the ADC 
value and tumor cellularity has been shown [4].
MRI is an ideal tool to evaluate lymph nodes 
of the mediastinum due to its excellent soft tissue 
contrast [5]. Mean ADC for malignant mediastinal 
lesions could be lower than that for benign en-
tities [6]. DW-MRI could improve the diagnostic 
accuracy in differentiation between benign and 
malignant mediastinal lymph nodes [4]. Diffe-
rentiation of treatment-induced tissue changes, 
after chemotherapy and radiotherapy is another 
area in which DW-MRI may be helpful. A further 
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possible application could be monitoring of tumor 
response during radiotherapy [7].
The study investigated the efficacy of diffusion 
weighted MRI in evaluation and characterization 
of mediastinal lymphadenopathy with histopa-
thological correlation as a reference standard to 
differentiate benign from malignant lymph nodes.
Material and methods
This prospective study included 30 patients 
with mediastinal lymphadenopathy, it has been 
conducted in the Chest Department in collabora-
tion with the Diagnostic Radiology Department, 
Faculty of Medicine, Cairo University Hospitals. 
Research ethics committee, the Faculty of Medi-
cine, Cairo University approved the study. All pa-
tients above 18 years, whether smoker or not, with 
no sex predilection, presenting with enlarged 
mediastinal lymph nodes of different etiologies 
were included. Subjects with refractory hypoxia, 
unfit for bronchoscopy or tissue biopsy, coagulo-
pathy, severe claustrophobia, cardiac pacemakers, 
metallic splinters were excluded. Patients were 
subjected to history taking, clinical examination 
and laboratory investigations, e.g.; complete 
blood picture, coagulation profile, renal and liver 
function tests, radiological assessment, inclu-
ding CT chest to detect mediastinal lymph node 
enlargement and diffusion weighted MRI using 
1.5 Tesla Philips Achieva Medical Systems, Best; 
The Netherlands, Release 3.2.3.4, SRN: 33078, 
with a 30 mT/m maximum gradient capability.
MRI protocol and technique 
MRI scanning protocol used was the follo-
wing: T1WI, T2WI & T2 STIR, DWI & quantitative 
DWI analysis (ADC measurement). DWI is typical-
ly acquired in transverse plane, using at least two 
b values; low (0−50 s/mm2) and intermediate to high 
b values (400−1000 s/mm2). Typical slice thick-
ness is 4−9 mm with interslice gap of 0−1.5 mm 
and a number of excitations ranges from 1−10. All 
DWI data were transferred to computer worksta-
tion for determination of signal intensity and 
ADC. ADC map was automatically reconstructed 
by standard software imager. ADC was measured 
by manually placing regions of interest on the 
ADC map. Necrotic areas were excluded from 
analysis. We used ADC b value (the diffusion 
gradient strength) 0−1000 values to achieve 
high accuracy in the detection of the nature of 
mediastinal lymph nodes, mainly by improving 
detection of subcentimeteric ones. Data from 
DW-MRI were assessed. In qualitative assessment, 
each lesion was evaluated on conventional images 
for location, size and presence of cystic necrotic 
parts. Each lesion signal intensity was evaluated 
in all pulse sequences T1WI, T2WI, STIR WI and 
its signal in DWI and ADC map were compared. In 
quantitative assessment, ADC value is calculated 
for each pixel of the image and is displayed as 
parametric map. ADCs of different tissues were 
constructed from b = 0 and b = 1000 sec/mm2 
values by drawing regions of interests on these 
maps using round or elliptical region of interest 
(ROI). ROI was drawn centrally and its size was 
kept as large as possible on ADC map covering at 
least two thirds of the lesion avoiding macroscopic 
necrosis and major blood vessel in the light of the 
conventional images, i.e. for entirely solid lymph 
nodes, regions of interest were placed over the 
entire lymph node. None of patients were under 
treatment when MRI was performed [8]. 
When evaluating diffusion weighted images, 
some investigators used multiple ROI measure-
ments with minimum pixels and averaged the 
results (ADCavg) on ADC maps, while others 
have placed the ROI on hyperintense areas of the 
b1000 diffusion images and copied this ROI into 
the ADC map [9]. De Bondt et al. [10] suggested 
that if ADCavg values are to be used, necrotic 
areas of lymph nodes on conventional images 
should be excluded. Measurements were based on 
minimum ADC values, since using average ADC 
values would require multiple measurements to 
exclude necrotic areas, and it would conflict with 
the goal to search for parameters easy to use. Also, 
using multiple ROIs could decrease sensitivity for 
detecting small lymph nodes. 
Lymph nodes biopsies were obtained either 
by EBUS-guided transbronchial needle aspiration, 
ultrasound or CT guided tru-cut needle biopsy, 
lymph no de excisional biopsy from peripherally 
enlarged lymph nodes in cases of generalized 
lymphadenopathy. Finally, DW-MRI ADC values 
were compared to histopathological results as 
a reference standard. 
Statistical analysis
Data were collected, tabulated and statistical-
ly analyzed, using SPSS 22.0 for windows (SPSS 
Inc., Chicago, IL, USA). All tests were two-sided. 
A p-value < 0.05 was considered significant. 
Continuous variables were expressed as mean, 
and standard deviation (SD) and categorical va-
riables were expressed as a number (percentage). 
Continuous variables were checked for normality 
by using the Shapiro–Wilk test. Independent 
samples Student’s  t-test was used to compare 
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Table 1. Comparison between the malignant and benign study groups
Variables Group P value
Malignant (N = 17) Benign (N = 13)
Age (median) 52 50 > 0.05$$
Sex distribution (N&%)
    Male
    Female
12 (40%)
5 (16.7)
1 (3.3%)
12 (40%)
< 0.001#
Smoking status
    Ex-smoker
    Smoker
    Non-smoker
1 (3.3%)
11 (36.7%)
5 (16.7)
2 (3.3%)
0 (0%)
12 (40%)
< 0.001#
No of total LN in CT (mean ± SD) 3.29 ± 1.69 3 ± 1.29 5^
Size of LN in CT
Station 4R (median) 2.25 2 < 0.05$$
Station 7 (mean ± SD) 3.57 ± 1.09 2.87 ±  0.96 > 0.05^
Station 10 (mean ± SD) 2.65 ± 1.043 2.32 ± 0.598 > 0.05^
Total size (median) 2.25 1.83 > 0.05$$
No of total LN in DW-MRI (mean ± SD) 2.71 ± 1.047 2.62 ± 1.044 > 0.05^
ADC of LN in DW-MRI
ADC Station 4R (mean ± SD) 0.89 ± 0.246 1.44 ± 0.494 < 0.001^
ADC Station 7 (median) 1.07 1.76 < 0.01$$
ADC Station 10 (mean ± SD) 1.12 ± 0.275 1.34 ± 0.323 > 0.05^
Total ADC (mean ± SD) 1.02 ± 0.318 1.43 ± 0.340 < 0.01^
Size of LN in DW-MRI
Station4R (median) 2.91 2.09 < 0.05$$
Station 7 (mean ± SD) 4.223 ± 1.422 3.547 ± 0.881 > 0.05^
Station 10 (median) 2.995 2.755 > 0.05$$
Total size (median) 3.24 2.93 > 0.05$$
$$Mann-Whitney U test; #Pearson Chi-Square; ^Student’s t-test; P considered significant if < 0.05. 
Station 4R: Rt lower paratracheal lymph nodes, Station 7: Subcarinal lymph nodes, Station 10: Hilar lymph nodes.
NB: In Station 2R (Rt upper Paratracheal lymph nodes), Station 5 (Aortopulmonary lymph nodes) and Station 6 (Para-aortic lymph nodes) the comparisons were invalid 
duo to presence of lesion in one group rather than the other
between two groups of normally distributed data 
while the Mann–Whitney U test was applied for 
nonnormally distributed data. Anova test was 
used to compare between more than two groups 
of normally distributed data while Kraskall Wallis 
H test was used to compare between more than 
two groups of nonnormally distributed data. The 
percent of categorical variables were compared 
using Pearson’s Chi-square test or Fisher’s exact 
test, when appropriate. Pearson’s correlation was 
calculated to assess the correlations between 
various study parameters. (+) sign indicate po-
sitive correlation and (-) sign indicate negative 
correlation. Receiver operating characteristic 
(ROC) curve analysis was used to identify optimal 
cutoff values of ADC with maximum sensitivity 
and specificity for prediction of malignancy. 
Area under the curve (AUC) was also calculated, 
> 0.60−0.70 was considered acceptable. 
Results
Thirty patients with mediastinal lymphadeno-
pathy were enrolled in the study. Their mean age 
was 46.6 years. Males constituted 43.33% while 
females — 56.67%. The majority of patients were 
nonsmokers (56.67%). 14 subjects (46.67%) were 
diagnosed by EBUS-guided TBNA and another 14 
patients (46.67%) were diagnosed by image-guided 
tru-cut needle core biopsy and 2 individuals (6.67%) 
were diagnosed by excisional LN biopsy. Final hi-
stopathological diagnoses included 17 malignant 
(56.7%) and 13 benign cases (43.3%). Moreover, 
malignant cases consisted of lymphoma (7 cases, 
23.3%) and metastatic lymph nodes (10 cases, 
33.3%). Benign diagnoses comprised sarcoidosis 
(10, 33.3%) and tuberculous lymphadenitis (3, 10%).
Table 1 showed a comparison between benign 
and malignant cases regarding demographic data, 
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Figure 1. A. Total ADC value reported by DW-MRI; B. ADC value of station 4R (right lower paratracheal LN); C. ADC value of station 7 (subcarial 
LN); D. total ADC value of the 4 histopathological subgroups; E. ADC value of station 4R in the 4 histopathological subgroups; F. ADC value of station 
7 in the 4 histopathological subgroups
CT and DW-MRI findings. Total mean ADC of LNs 
in the malignant group was 1.02 while in the 
benign group — 1.43 with significant statistical 
difference (P < 0.01) (Figure 1A). Station 4R and 
station 7 (Figure 1A, 1B) were sensitive in diffe-
rentiation between benign and malignant lesion 
as regarding ADC. Station 4R LN size was signifi-
cantly larger in malignant than the benign group 
(P < 0.05). Table 2 showed significant difference 
between various study histopathological subgro-
ups regarding demographic data, total ADC in 
affected LNs and ADC value of 4R station (Figure 
1D, 1E). But ADC of station 7 (Figure 1F) wasn’t 
significantly different. Also, station 4R median 
size showed significant difference between the 
4 subgroups.
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Table 2.  Comparison between the different histopathological subgroups of the study (Metastatic/Lymphoma/Sarcoidosis/ 
/Tuberculosis)
Variables Groups P value
Metastatic (N = 10) Lymphoma (N = 7) Sarcoidosis (N = 10) TB (N = 3)
Age (mean ± SD) 58.3 ± 9.76 36.429 ± 16.4 46.7 ± 11.33 31 ± 22.6 < 0.01^^
Sex distribution (N&%)
    Male
    Female
10 (100%)
0
2 (28.6%)
5 (71.4%)
1 (10%)
9 (90%)
0
3 (100%)
< 0.001#
Smoking status (N&%)
    Ex-smoker
    Smoker
    Non-smoker
1 (10%)
9 (90%)
0
0
2 (28.6%)
5 (71.4%)
1 (10%)
0
9 (90%)
0
0
3 (100%)
< 0.001#
ADC of LN in DW-MRI
ADC Station 4R (mean ± SD) 0.88 ± 0.3 0.91 ± 0.15 1.48 ± 0.57 1.32 ± 0.27 < 0.05^^
ADC Station 7 (median) 1.089 0.998 1.698 1.76 > 0.05$
ADC Station 10 (mean ± SD) 1.05 ± 0.21 1.23 ± 0.38 1.33 ± 0.34 1.45 > 0.05^^
Total ADC (mean ± SD) 1 ± 0.37 1.04 ± 0.26 1.42 ± 0.37 1.45 ± 0.25 < 0.05^^
Size of LN in DW-MRI
Station 4R (median) 2.83 3.185 1.995 3.19 < 0.01$
Station 7 (mean ± SD) 4.15 ± 1.2 4.39 ± 2.23 3.39 ± 0.91 4.18 ± 0.49 > 0.05^^
Station 10 (mean ± SD) 2.79 ± 0.88 3.69 ± 0.9 2.93 ± 0.8 2.02 ± 0 > 0.05^^
Total size of LN in DW MRI 
(median)
3.16 3.77 2.83 3.61 > 0.05$
$Kruskal–Wallis One Way Analysis of Variance on Ranks; #Pearson Chi-Square; ^^One-way ANOVA test, P considered significant if < 0.05.
Station 4R: Rt lower paratracheal lymph nodes, Station 7: Subcarinal lymph nodes, Station 10: Hilar lymph nodes.
NB: In Station 2R (Rt upper Paratracheal lymph nodes), Station 5 (Aortopulmonary lymph nodes) and Station 6 (Para-aortic lymph nodes) the comparisons were invalid 
duo to presence of lesion in one group rather than the others
Significant negative correlation between total 
ADC value and size of LN was reported by DW- 
-MRI (r = -0.373, P < 0.05) (Figure 2A), while CT 
chest showed insignificant negative correlation 
(r = -0.232, P > 0.05) (Figure 2B). The best ADC 
cutoff point to differentiate malignant from beni-
gn lesion was 1.15 mm/sec with sensitivity 77%, 
specificity 92%, and area under the curve (AUC) 
was 81.4% (Figure 3A). Sensitivity, specificity, PPV, 
NPV and accuracy (ACC) of ADC for malignancy 
diagnosis at cutoff point ≤ 1.15 were 77%, 92%, 
92.9%, 75% and 83.3%, respectively. The best ADC 
cutoff point to differentiate between sarcoidosis 
and other lesions was > 1.15 mm/sec with sen-
sitivity 90%, specificity 65% and AUC was 75% 
(Figure 3B). Sensitivity, specificity, PPV, NPV and 
accuracy of ADC for sarcoidosis diagnosis at cutoff 
point > 1.15 were 90%, 65%, 56%, 93% and 73%, 
respectively.
Discussion
To date, diagnosis of lymph node metasta-
ses is based mainly on size criteria; however, 
non-enlarged nodes may harbor malignancy, 
whereas reactive nodes may be enlarged. SPECT 
(single photon emission CT) and PET (photon 
emission tomography) are image techniques 
which supply functional information but being 
expensive, they are not easily available, additio-
nally, they involve exposure to radiation [4]. 
Promising results with DWI that help detect 
lymph node metastases and differentiate be-
tween benign and malignant enlarged nodes have 
been reported [11]. 
This work evaluated diagnostic accuracy of 
DW-MRI in discriminating benign and malignant 
lymph nodes — the issue, which is crucial in dia-
gnosis and management of patients with media-
stinal lymphadenopathy using histopathological 
results as standard reference.
In this study, malignant cases constituted 56.7% 
while benign cases — 43.3%. Malignant cases were 
further subdivided into lymphoma (7, 23.3%) (Fi-
gure 4) and metastatic lymph nodes (10, 33.3%). 
Benign cases included sarcoidosis (10, 33.3%) and 
tuberculous lymphadenitis (3, 10%). This was simi-
lar to Sabri et al. [12] study (included 13 patients 
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Figure 2. A. Correlation between the total ADC value and total size of LNs reported by DW-MRI (r = -0.373, P value 0.042); B. Correlation between 
the total ADC value and the total size of LNs reported by CT (r = -0.232 p value = 0.271)
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Figure 3. A. ROC curve of the total ADC values of malignant cases reported by DW-MRI (cutoff point ≤ 1.15 mm/sec, sensitivity 77%, specificity 
92% and AUC 81.4%); B. ROC curve of the total ADC value of sarcoidosis cases reported by DW-MRI (cutoff point > 1.15 mm/sec, sensitivity 90%, 
specificity 65% and AUC 75%) 
with mediastinal lymphadenopathy; 6 pathological-
ly proven as sarcoidosis and 7 as lymphoma).
There was a significant difference between 
the 4 histopathological subgroups regarding age 
and sex. Also, smoking was significantly associa-
ted with the metastatic group. Median size of LNs 
reported by DW-MRI in the malignant group was 
3.24 cm opposite to 2.93 cm in the benign one 
with no significant difference. This confirms the 
fact that size of LNs doesn’t matter in differen-
tiating benign from malignant nodes. ADC values 
in stations 4R and 7 were sensitive in differen-
tiating benign and malignant lesions (Figure 1). 
Mean ADC value of LNs in the malignant group 
was 1.02 ± 0.32 while in the benign, it was 1.43 
± 0.34 with a significant difference in-between 
(P < 0.01). This agreed with Vandecaveye et al. 
[13] who correlated histopathologic and radio-
logic findings for lymph nodes (ADC value was 
1.19 ± 0.22 for benign LNs and 0.85 ± 0.27 for 
malignant LNs; P < 0.001). Also, Seber and his 
colleagues [14] illustrated that mean ADC value 
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Figure 4. A. Axial contrast CT chest mediastinal window showing amalgamated nodal masses encasing main branches of aortic arch and SVC; 
B. Axial CT chest; pulmonary window showing a dense nodule at apicoposterior of the left upper lobe; C. DW MRI; Axial MR T2WI, axial DWI and 
ADC map, respectively showing low T2 signal intensity with restricted diffusion higher DWI signal and lower ADC value. The mean ADC for the 
amalgamated nodal mass was 0.984 × 10−3 mm2/s. Restricted diffusion suggest malignant nature, mostly lymphoma. Tru-Cut needle biopsy 
obtained from this amalgamated nodal mass and histopathology revealed large cell type malignant lymphoma.
A
C
B
for benign LNs was 0.97 and for malignant LNs 
was 0.76 (P < 0.001). 
There was a significant statistical difference 
between the 4 histopathological subgroups regar-
ding ADC value in station 4R and ADC of all affec-
ted LNs. It was higher in TB and sarcoidosis (ADC; 
1.45 ± 0.25 and 1.42 ± 0.37, respectively) than 
in the metastatic and lymphoma groups (ADC; 
1 ± 0.37 and 1.04 ± 0.26, respectively). The same 
was reported by Gümüştaş et al. [15] who stated 
that ADC value for lymphoma was 1.130 ± 0.581 
and for sarcoidosis was 2.065 ± 0.518. Also, 
Sabri et al. [12] showed that ADC for lymphoma 
(1.22 ± 0.23) was lower than that of sarcoidosis 
(1.9±0.28), and the difference was statistically 
significant. Vandecaveye et al. [13] again, reported 
that metastatic and lymphomatous nodes present 
reduction of diffusivity, which can be attributed 
to hypercellularity, cellular pleomorphism, incre-
ased mitosis and nuclear-to-cytoplasmatic ratio. 
Similarly, Kosucu et al. [16] found that ADC value 
is significantly lower in metastatic (1.01 ± 0.02) 
than in benign nodes (1.51 ± 0.07).
This study attempted to differentiate meta-
static carcinoma and lymphoma on basis of their 
ADC values, but ADC value of lymphoma (1.04 
± 0.26) was not significantly different from that 
of metastatic carcinoma (1 ± 0.37). In contrast, 
statistically significant results were illustrated 
by King and colleagues [17] between ADC of 
metastatic nodes (1.057) and lymphoma (0.664) 
(P < 0.01). Differences in restriction of diffusion 
may be attributed to differences in cellularity, 
necrosis and perfusion. Greater cellularity and 
less extracellular space may lead to restriction of 
diffusion in lymphoma rather than in carcinomas. 
Again, Sumi and colleagues [18] reported that 
ADC of metastatic nodes was significantly higher 
(1.167 ± 0.4) than benign lymphadenopathies 
(0.652 ± 0.10) and lymphomatous ones (0.601 ± 
0.427). These differences in the results may be 
due to the choice of the b values (lower b values 
increase signal-to-noise ratio but may worsen 
the sensitivity to diffusion ratio), the selection of 
the region of interest on ADC maps and the use 
of sequences which reduce artifacts in order to 
make more precise measurement of the area of 
interest. This was described by Wang and colle-
agues [19] who stated that in benign LNs, a false 
decrease in ADC may correlate with the presence 
of nodal reactive changes that manifest as mul-
tiple germinal centers and fibrotic stroma, which 
act as microstructural barriers. Also, Choi and 
colleagues [20] stated that false-positive readings 
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may be caused by restricted diffusion in recent 
hemorrhage or hematoma. Therefore, DWI should 
not be performed directly after biopsy. 
This study showed significant negative corre-
lation between ADC value and size of LNs repor-
ted by DW-MRI. While with CT chest, correlation 
was insignificantly negative. The best cutoff point 
of ADC value to differentiate between malignant 
and benign nodes was 1.15 mm/sec with sensiti-
vity 77%, specificity 92%, and AUC 81.4%. PPV, 
NPV, and ACC of this ADC value in diagnosis of 
malignancy were 92.9%, 75% and 83.3%, respec-
tively. Also, the best cutoff point of ADC value 
to differentiate between sarcoidosis and other 
lesions was > 1.15 with sensitivity 90%, speci-
ficity 65%, and AUC 75%. PPV, NPV and ACC of 
this ADC value in diagnosis of sarcoidosis were 
56%, 93% and 73%, respectively. Vandecaveye et 
al. [13] showed that with an optimal ADC thre-
shold of 0.94, sensitivity, specificity and accuracy 
for differentiation of malignant versus benign 
lymph nodes were 84%, 94% and 91%, respec-
tively. Also, Tondo et al. [21] used ADC value of 
1.25 as threshold to differentiate malignant from 
benign lesions with a 91% diagnostic accuracy, 
90% sensitivity, 100% PPV and 57% NPV. Seber 
and colleagues [14] showed that in ROC analysis, 
the cutoff ADC value for malignant versus benign 
LNs differentiation was 0.8. Using an ADC value 
of 0.8, the sensitivity, specificity, PPV, NPV and 
accuracy for differentiating between benign and 
malignant LNs were 76.4%, 85.7%, 86.6%, 75%, 
and 80.6%, respectively. Also, Ragheb and colle-
agues [22] stated that optimal ADC cutoff value 
for differentiating benign and malignant LNs 
was 0.61 with accuracy 96.7%, sensitivity 100%, 
specificity 88.9%, PPV 95.4% and NPV 100%. 
Again, Holzapfel and colleagues [23] reported an 
accuracy of 94% in characterizing metastatic LNs 
when using threshold of 1.02. However, Abdel 
Razek and colleagues [24] reported slightly higher 
threshold (ADC:1.38) for characterizing suspected 
LNs with accuracy of 96%. Although both authors 
used similar MR sequence, the difference in ADC 
values may be due to the fact that Holzapfel 
and colleagues [23] calculated their ADC maps 
from 3 different b-values. Also, Perronea et al. 
[4] reported that ADC value for malignant le-
sions was 0.85, which is lower than benign LNs 
(ADC;1.448), and the best ADC threshold value 
for distinguishing benign from malignant nodes 
was 1.03 with sensitivity 100% and specificity 
92.9%. 
This study has some limitations such as 
a small study cohort in a single center. However, 
statistical tests were performed on the number of 
involved nodes (about 95 nodes) rather than the 
number of the patients. Finally, we can conclude 
that DW-MRI can noninvasively differentiate be-
nign from malignant mediastinal lymphadenopa-
thy and differentiate lymphoma from sarcoidosis. 
When compared to PET/CT, there is no exposure 
to ionizing radiation, no need for administration 
of external tracer and moreover, this technique is 
less expensive. DW-MRI offers unique combina-
tion of morphological and functional information 
in a single examination without radiation burden. 
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